Progyny Stock (NASDAQ:PGNY)
Previous Close
$23.25
52W Range
$19.60 - $42.08
50D Avg
$24.95
200D Avg
$31.86
Market Cap
$2.18B
Avg Vol (3M)
$1.37M
Beta
1.44
Div Yield
-
PGNY Company Profile
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
PGNY Performance
Peer Comparison
| Ticker | Company |
|---|---|
| PHR | Phreesia, Inc. |
| TXG | 10x Genomics, Inc. |
| NRC | National Research Corporation |
| VEEV | Veeva Systems Inc. |
| PRVA | Privia Health Group, Inc. |
| SLP | Simulations Plus, Inc. |
| EVH | Evolent Health, Inc. |
| GDRX | GoodRx Holdings, Inc. |
| DH | Definitive Healthcare Corp. |
| HSTM | HealthStream, Inc. |
| CERT | Certara, Inc. |
| TDOC | Teladoc Health, Inc. |
| HCAT | Health Catalyst, Inc. |